Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs VanEck Semiconductor ETF (SMH) Price & Performance

BridgeBio Pharma IncTrade
VanEck Semiconductor ETFTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs VanEck Semiconductor ETF — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while VanEck Semiconductor ETF trades at $581. Which is the better fit depends on your goals.

BBIOSMH
Market Cap
$16.36B
Sector
Health
52-Week High
$90.17$668.91
52-Week Low
$47.29$286.43
Enterprise Value
$18.14B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About VanEck Semiconductor ETF

The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.

Read more on SMH